
Good manufacturing practice | European Medicines Agency (EMA)
Good manufacturing practice (GMP) describes the minimum standard that a medicines manufacturer must meet in their production processes. The European Medicines Agency …
EudraLex - Volume 4 - European Commission - Public Health
Oct 8, 2003 · Volume 4 of "The rules governing medicinal products in the European Union" contains guidance for the interpretation of the principles and guidelines of good manufacturing …
Guidance on - European Medicines Agency (EMA)
The European Medicines Agency's (EMA) provides answers to frequently asked questions on good manufacturing practice (GMP) and good distribution practice (GDP), as discussed and …
EudraGMDP database | European Medicines Agency (EMA)
The EudraGMDP database is the Community database on manufacturing, import and wholesale-distribution authorisations, and good manufacturing-practice (GMP) and good-distribution …
Good Manufacturing and Distribution Practices
The EU has MRAs on GMP with Australia, Canada, Israel, Japan, New Zealand, Switzerland and the United States. All these agreements cover human/veterinary medicines; however the …
Home · IRIS
Increase efficiency on reporting inspections data and create a better overview of scientific/regulatory data by managing your inspections for GMP, GCP and GVP processes via …
EMA: No further Extension of GDP Certificates in 2025
Mar 11, 2025 · The GMP/GDP Inspectors Working Group decided at the end of 2023 to extend the validity of GDP and GMP certificates that expired at the end of the year until 2024 or until …
Directive - 2017/1572 - EN - EUR-Lex
Principles and guidelines of good manufacturing practice for medicinal products for human use should be set out in relation to quality management, personnel, premises and equipment, …
GMP Update 2024/2025 - GMP Journal
Feb 19, 2025 · On January 26, 2024, the European Medicines Agency (EMA) published the new ICH Q14 Guideline "Analytical Procedure Development" as Step 5. It has been in force since …
The EMA validates submissions to the centralised system and determines whether or not an inspection of the manufacturing, control, batch release and importation site(s) concerned is …
- Some results have been removed